Quick facts
- A prescription for eyeglasses is defined in the United States as the written specifications for lenses derived from a refractive eye examination, including all the information State law requires to obtain lenses: 16 CFR 456.1(g).
- The release duty is federal in the United States. The Ophthalmic Practice Rules in 16 CFR part 456 prohibit a prescriber from conditioning release of the prescription on payment or on buying glasses from that practice.
- Canada has no comparable federal trade rule. The professionals who refract and the professionals who dispense are licensed provincially, and the obligations that attach to the record come from the provincial regulator rather than from a federal instrument.
- The eyewear itself is Class I on both sides: a prescription spectacle lens, a spectacle frame and magnifying spectacles each hold their own Class I entry in the United States, and Canada reaches Class I through Rule 7(1).
- Record retention is the quiet difference: the United States rule requires evidence of prescription release to be kept for not less than three years and to be available for inspection.
- None of this is clinical guidance; it is the paperwork that sits behind a dispensing decision.
Eyewear is the one part of eye care where the buyer is also the patient, and the rules that govern the transaction are commercial rather than clinical. The United States regulates the transaction directly, at federal level, through the Eyeglass Rule. Canada regulates the professionals, provincially, and leaves the commercial step to the relationship between the prescriber and the dispenser. That difference shows up on the counter in very practical ways, and it is worth knowing before a clinic, an optical dispensary or a purchasing manager builds a workflow around it.
What is on an eyewear prescription, and which parts are regulated?
A prescription is a measurement record. It has to survive the trip from the lane to the bench without being reinterpreted.
| Element | What it records | Why it matters at the bench |
|---|---|---|
| Sphere | The power needed to correct the main refractive error | Written in dioptres, the metre-based unit of lens power |
| Cylinder and axis | The astigmatic correction and its orientation in degrees | A transposed axis produces the wrong lens, not a worse lens |
| Add | The additional power for near vision | Applies to reading and progressive designs |
| Prism and base | A prismatic correction and the direction of its base | Requires the base direction to be stated, not implied |
| Pupillary distance | The distance between optical centres | Two measurements are common: one for distance and one for near |
| Expiry or review interval | When the record should be refreshed | Set by the prescriber's practice, not by the retailer |
The elements are the same on both sides of the border because the units are the same. Dioptres and prism dioptres are international units, and a lens is a lens. What differs is who is entitled to write the numbers down, who is entitled to act on them, and what has to be kept afterwards.
How does prescription release differ between Canada and the United States?
This is the section that matters, and the two countries are not mirror images.
United States. 16 CFR 456.2 prohibits a prescriber from doing four things: requiring a patient to purchase ophthalmic goods as a condition of the examination, conditioning availability of an examination on an agreement to buy from that practice, charging an additional fee as a condition of releasing the prescription, and placing a waiver or disclaimer of responsibility on the prescription or requiring the patient to sign one. The section permits an additional fee for verifying goods dispensed by another seller when the fee is charged at the time the verification is performed.
16 CFR 456.4 then requires the prescriber to retain evidence that the prescription was sent, received, or made accessible, downloadable and printable, for not less than three years, available for inspection by the Federal Trade Commission. It also sets out a carve-out: the confirmation requirement does not apply to prescribers who have no direct or indirect financial interest in the sale of eyewear, including through an association, affiliation or co-location with a dispenser.
Canada. There is no federal equivalent. Refraction and dispensing are provincial matters, and the college standards that apply to a regulated optometrist or optician are the instrument that governs how the record is handled. The result is not that Canadian patients have no remedy; it is that the rule is not a federal trade rule, so it does not operate as a national floor in the way the United States instrument does.
| Item | Canada | United States |
|---|---|---|
| Federal trade rule on prescription release | None | 16 CFR part 456 |
| Who licenses the professionals | Provincial regulators | State boards, with a federal trade overlay |
| Record retention for release evidence | Set by the provincial regulator and the practice | Not less than three years under 16 CFR 456.4 |
| Charging to release the prescription | Not addressed by a federal instrument | Prohibited by 16 CFR 456.2(c) |
| Exemption for prescribers with no eyewear interest | Not applicable at federal level | Applies to the confirmation duty in 16 CFR 456.4(c) |
| Digital format | Practice-specific | Consent requirements in 16 CFR 456.3 |
| The lenses themselves | Rule 7(1) Class I | 21 CFR 886.5844 Class I, exempt subject to 886.9 |
Does a digital prescription change anything?
It changes what has to be recorded, in the United States. 16 CFR 456.3 requires a prescriber who provides the prescription copy in a digital format to identify the specific method of electronic delivery that will be used, such as text message, electronic mail or an online patient portal; to obtain the patient's verifiable affirmative consent to receive a digital copy through those methods, on paper or in a digital format; and to keep records or evidence of that consent for not less than three years.
In Canada the digital step is a records question rather than a consent rule in the same form, because there is no federal instrument to hang the consent requirement on. A practice that operates in both countries has to run the stricter of the two, and the stricter of the two on this point is the United States requirement.
What should a practice be able to show an inspector or an auditor?
Five items cover the ground.
- The prescription as released. The written record of the measurement, with the elements a lab needs to make the lenses.
- Evidence of release. Where the United States rule applies, evidence that the copy was sent, received or made accessible, retained for at least three years.
- The consent record, where digital delivery is used. The method identified and the patient's affirmative consent.
- The separation of fees. An examination fee and a verification fee are separate things, and the record should not merge them.
- The lens and frame specification. If the practice dispenses, the specification of what was supplied belongs with the order, not only with the invoice.
Which consumables does the dispensary and lane go through?
The lane and the dispensing bench consume table paper, swabs, wipes, gloves and dressing supplies in the same cycle as the frames. For clinics and dispensaries buying at case level, the wholesale ordering page sets out account and case terms, and the B2B wholesale collection lists the lines held for institutional buyers. The examination table paper roll covers the lane, the eye test chart set with Snellen and Amsler charts covers the refraction side, and clinics that also run an in-house sterilizer can start with the biological indicator 5-pack trial and the sterilization monitoring collection.
Sources
- 16 CFR part 456, Ophthalmic Practice Rules (Eyeglass Rule)
- 16 CFR 456.1, definitions
- 16 CFR 456.2, separation of examination and dispensing
- 16 CFR 456.3, verifiable affirmative consent to a digital prescription
- 16 CFR 456.4, confirmation of prescription release
- 21 CFR 886.5844, prescription spectacle lens
- 21 CFR 886.5842, spectacle frame
- 21 CFR 886.5840, magnifying spectacles
- 21 CFR 886.5850, sunglasses (nonprescription)
- 21 CFR 886.9, limitations of exemptions
- Medical Devices Regulations, SOR/98-282, full text and Schedule 1
- Health Canada, medical devices
- College of Optometrists of Ontario, standards of practice
- Canadian Association of Optometrists, eye health library
- openFDA device classification API
- FDA device classification database
- National Eye Institute, eye health information
- American Academy of Ophthalmology, eye health
- ISO 15004-1:2020, ophthalmic instruments, general requirements
- World Health Organization, blindness and visual impairment
Related reading
- Eyeglass Frame Sizing in Canada vs the US: Which Measurement System Applies
- Eye Chart in Canada vs the US: Which Optotype Standard Applies
- Comprehensive Eye Check-Up in Canada vs the US: Which Exam Interval Applies
- Near Vision Reading Cards in Canada vs the US: Which Rules Apply
CliniEco Medical supplies eye care, laboratory and clinic consumables of the kind described in this article. MDEL #35334. This article is written for clinic, procurement and infection-control professionals and is not clinical guidance; prescribing and dispensing decisions belong to the licensed professional.
Frequently Asked Questions
Is there a federal rule in Canada that requires an eyewear prescription to be released?
No. The release rule in the United States is a federal trade rule in 16 CFR part 456 implemented by the Federal Trade Commission. Canada has no comparable federal instrument, so the obligations that attach to refraction and dispensing records come from the provincial regulator that licenses the professional.
What does the United States eyeglass rule prohibit?
It prohibits a prescriber from requiring a patient to buy ophthalmic goods as a condition of the examination, from conditioning the availability of an examination on an agreement to buy from that practice, from charging an additional fee as a condition of releasing the prescription, and from placing a waiver or disclaimer of responsibility on the prescription or requiring a patient to sign one.
How long must evidence of prescription release be kept?
In the United States, not less than three years. Section 456.4 requires the prescriber to retain records or evidence that the prescription was sent, received, or made accessible, downloadable and printable, and makes those records available for inspection by the Federal Trade Commission.
Who is exempt from the confirmation duty?
Prescribers who have no direct or indirect financial interest in the sale of eyewear, including through an association, affiliation, or co-location with an optical dispenser. The exemption is set out in section 456.4(c) and applies to the confirmation duty rather than to the whole part.
Are eyeglass lenses a regulated device?
Yes, and they are Class I on both sides. In the United States a prescription spectacle lens is covered by 21 CFR 886.5844, a spectacle frame by 886.5842 and magnifying spectacles by 886.5840, each exempt from premarket notification subject to 21 CFR 886.9. In Canada the lens and the frame are non-invasive devices reached by Rule 7(1) and are Class I.
What is required if the prescription is provided digitally?
In the United States, the prescriber must identify the method of electronic delivery, obtain the patient's verifiable affirmative consent to receive a digital copy through that method, and keep records of the consent for not less than three years. That is the requirement of 16 CFR 456.3, and it operates alongside the release duty rather than replacing it.
0 commentaire